The A. Catalyst Network is a local approach designed to boost global health outcomes. Take one of the pressure points, chronic disease.
Meanwhile, public-sector bodies like universities are traditionally strong healthcare collaborators. When it comes to the private sector though, partnerships like joint working have been much more quid pro quo. Catalyst Network is another particularly interesting example.
Catalyst Network A. CN was set up by AstraZeneca in Today it is a collection of 26 hubs spread across the globe, which in their own words, exist to accelerate and scale solutions that will improve equitable access to healthcare and help make healthcare ecosystems more resilient in the face of change.
Big organisations have big partnerships. These strategic partnerships will move the industry forward in the long term. This is one of A. CN hubs are spread around the globe from Mexico to Malaysia. They are also disconnected from AstraZeneca products, so they can focus on local healthcare challenges where AstraZeneca has expertise, free from the pressure of short-term sales targets.
Healthcare startups are a significant source of disruptive innovation that develops and uses emerging technologies to invent a new product or reinvent the existing one with high efficiency. As a startup though, you often lack resources or experience in areas like conducting clinical trials or how to integrate with hospital systems to make your innovation have practical value etc.
